Astrazeneca

Mix-and-match vaccines highly effective against COVID-19: Lancet study

During a 2.5-month average follow-up period after the second dose, the study showed a 67 per cent lower risk of infection for the combination of AstraZeneca and Pfizer vaccine shots.

published on : 18th October 2021

Antibody injection cuts severe COVID-19 risk, concludes AstraZeneca study

TACKLE included 903 participants in a 1:1 randomisation AZD7442 to placebo and the primary analysis was based on 822 participants.

published on : 11th October 2021

Drugmaker AstraZeneca asks US FDA to authorize COVID antibody treatment

The treatment, known as AZD7442, would be the first long-acting antibody combination to receive an emergency use authorization for COVID-19 prevention.

published on : 5th October 2021

New AstraZeneca tie-up to explore vaccine tech use for cancer, heart disease

VaxEquity was founded in 2020 by Imperial's Professor Robin Shattock and Morningside Ventures to develop transformative RNA therapeutics using its next generation saRNA platform.

published on : 28th September 2021

CoWin certificates to mention date of birth of fully vaccinated travelling abroad

Currently, CoWin certificates mention the beneficiary's age based on the year of birth besides other details.

published on : 25th September 2021

Not many places left for COVID to evade immunity: UK vaccine creator

The expert said that such viruses, by their very nature tend to become less virulent over time, but there is no set timeframe for how long that would take.

published on : 24th September 2021

COVID vaccine certification for travel must meet 'minimum criteria', says UK on its new norms

The declaration follows Covishield, the Serum Institute of India manufactured Oxford/AstraZeneca vaccine, being added as eligible to an expanded UK travel advisory on Wednesday.

published on : 23rd September 2021

Covid vaccines donated by India for peacekeepers exhausted: UN spokesperson

India, one of the largest troop-contributing countries to UN peacekeeping missions, had gifted 2,00,000 doses of AstraZeneca COVID-19 vaccines for UN peacekeepers across all UN missions.

published on : 18th September 2021

Bulgaria, EU's least vaccinated nation, faces deadly surge

Only 20% of adults in Bulgaria, which has a population of 7 million, have so far been fully vaccinated.

published on : 8th September 2021

Protection gained after vaccination wanes in months: UK study on COVID-19

With Oxford/AstraZeneca, being administered in India as Covishield, the fall was from 77 per cent to 67 per cent at four to five months.

published on : 25th August 2021

AstraZeneca vaccine: Researchers define criteria for diagnosis of patients with blood clotting

The research found that the overall mortality rate of those presenting to hospitals with definite or probable VITT was 23 per cent.

published on : 24th August 2021

Japanese Foreign Minister discusses de-escalation with Iranian officials

Iranian President Ebrahim Raisi said he is opposed to the creation of insecurity in the region, adding: "The presence of Americans in the region, including Afghanistan, has not provided security."

published on : 22nd August 2021

Facebook bans firm behind Pfizer, AstraZeneca smear campaign

A network of 65 Facebook accounts and 243 Instagram accounts was traced back to Fazze, an advertising and marketing firm registered in the United Kingdom.

published on : 11th August 2021

Japan donates 500,000 doses of AstraZeneca vaccine to Nepal; another 1.1 million jabs promised

The first batch consisting of 513,420 doses of the Japan-made vaccine arrived on a Qatar Airways flight in Tribhuvan International Airport, Kathmandu on Saturday, said the health ministry.

published on : 7th August 2021

COVID-19: Japan donates 1.4 million doses of AstraZeneca vaccine to Sri Lanka

The Japanese donation follows a personal request made by Sri Lanka president Gotabaya Rajapaksa to the Japan prime minister Yoshihide Suga, said a statement from the president's office.

published on : 3rd August 2021
1 2 3 4 5 6 >